1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Clinical Trials Market – By Phase

1.3.2        North America Clinical Trials Market – By Study Design

1.3.3        North America Clinical Trials Market – By Indication

1.3.4        North America Clinical Trials Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Clinical Trials Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Experts Opinion

5.           North America Clinical Trials Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Adoption and Outsourcing of Clinical Trials

5.1.2        Flourishing Pharmaceutical Industry and Increasing R&D Activities in Pharmaceutical Industry

5.2         Market Restraints

5.2.1        Expensive and Time-Consuming Process

5.3         Market Opportunities

5.3.1        Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials

5.4         Future Trends

5.4.1        AI-Driven Clinical Trials

5.5         Impact Analysis

6.           Clinical Trials Market – North America Analysis

6.1         North America Clinical Trials Market Revenue Forecast and Analysis

7.           North America Clinical Trials Market Revenue and Forecast To 2028 – by Study Design

7.1         Overview

7.2         North America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)

7.3         Interventional

7.3.1        Overview

7.3.2        Interventional: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Observational

7.4.1        Overview

7.4.2        Observational: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Expanded Access

7.5.1        Overview

7.5.2        Expanded Access: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Clinical Trials Market – By Phase

8.1         Overview

8.2         North America Clinical Trials Market, by Phase, 2022 and 2028 (%)

8.3         Phase III

8.3.1        Overview

8.3.2        Phase III: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Phase II

8.4.1        Overview

8.4.2        Phase II: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Phase IV

8.5.1        Overview

8.5.2        Phase IV: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Phase I

8.6.1        Overview

8.6.2        Phase I: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Clinical Trials Market Revenue and Forecast To 2028 – Indication

9.1         Overview

9.2         North America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)

9.3         Autoimmune/Inflammation

9.3.1        Overview

9.3.2        Autoimmune/Inflammation: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Pain Management

9.4.1        Overview

9.4.2        Pain Management: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Oncology

9.5.1        Overview

9.5.2        Oncology: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.6         CNS Condition

9.6.1        Overview

9.6.2        CNS Condition: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.7         Diabetes

9.7.1        Overview

9.7.2        Diabetes: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.8         Obesity

9.8.1        Overview

9.8.2        Obesity: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.9         Cardiovascular

9.9.1        Overview

9.9.2        Cardiovascular: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

9.10      Other

9.10.1     Overview

9.10.2     Other: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Clinical Trials Market – Revenue and Forecast to 2028 – Country Analysis

10.1      North America: Clinical Trials Market

10.1.1     Overview

10.1.2     North America: Clinical Trials Market, by Country, 2022& 2028 (%)

10.1.2.1       US: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.1       Overview

10.1.2.1.2       US: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.1.3       US: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)

10.1.2.1.4       US: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.1.5       US: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

10.1.2.2       Canada: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.1       Overview

10.1.2.2.2       Canada: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.2.3       Canada: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)

10.1.2.2.4       Canada: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.2.5       Canada: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

10.1.2.3       Mexico: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.1       Overview

10.1.2.3.2       Mexico: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

10.1.2.3.3       Mexico: Clinical Trials Market, by Phase, 2020-2028 (US$ Million)

10.1.2.3.4       Mexico: Clinical Trials Market, by Study Design, 2020-2028 (US$ Million)

10.1.2.3.5       Mexico: Clinical Trials Market, by Indication, 2020-2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Growth Strategies Done by the Companies in the Market, (%)

11.3      Organic Developments

11.3.1     Overview

11.4      Inorganic Developments

11.4.1     Overview

12.        Company Profiles

12.1      IQVIA Holdings Inc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Parexel International Corp

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      IXICO Plc

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Charles River Laboratories International Inc

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      ICON Plc

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      WuXi AppTec Co Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      SGS SA

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Syneos Health Inc

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Thermo Fisher Scientific Inc

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Laboratory Corp of America Holdings

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Canada: Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada: Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada: Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Mexico: Clinical Trials Market, by Phase – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Mexico: Clinical Trials Market, by Study Design – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico: Clinical Trials Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Organic Developments Done by Companies

Table 11.          Inorganic Developments Done by Companies

Table 12.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Clinical Trials Market Segmentation

Figure 2.           North America Clinical Trials Market, By Country

Figure 3.           North America Clinical Trials Market Overview

Figure 4.           Phase III Segment Held Largest Share of Phase Segment in North America Clinical Trials Market

Figure 5.           Canada is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           North America Experts Opinion

Figure 8.           Impact Analysis

Figure 9.           North America Clinical Trials Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        North America Clinical Trials Market Revenue Share, by Study Design (2022 and 2028)

Figure 11.        Interventional: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Observational: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Expanded Access: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Clinical Trials Market, by Phase 2022 and 2028 (%)

Figure 15.        Phase III: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Phase II: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Phase IV: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Phase I: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        North America Clinical Trials Market Revenue Share, by Indication (2022 and 2028)

Figure 20.        Autoimmune/Inflammation: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Pain Management: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Oncology: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        CNS Condition: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Diabetes: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Obesity: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Cardiovascular: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Other: North America Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        North America: Clinical Trials Market, by Key Country – Revenue (2022) (US$ Million)

Figure 29.        North America: Clinical Trials Market, by Country, 2022 & 2028 (%)

Figure 30.        US: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Canada: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Mexico: Clinical Trials Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Growth Strategies Done by the Companies in the Market, (%)